Trulicity
NDC 0002-1434, Dulaglutide, injection, solution, from Eli Lilly and Company.
- Product NDC
- 0002-1434
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125469
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1434 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DULAGLUTIDE1.5 mg/.5mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-1434-80 | 00002143480 | 4 SYRINGE in 1 CARTON (0002-1434-80) / .5 mL in 1 SYRINGE (0002-1434-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/463050bd-2b1c-40f5-b3c3-0a04bb433309NADAC price for package 00002143480
GET /v1/drugs/nadac/00002143480
Use it
Look up 0002-1434 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1434 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-1434. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.